z-logo
open-access-imgOpen Access
Targeting the SARS-CoV-2 3CL pro and NO/cGMP/PDE5 Pathway in COVID-19: A Commentary On PDE5 Inhibitors
Author(s) -
Milad Shirvaliloo
Publication year - 2021
Publication title -
future cardiology
Language(s) - English
Resource type - Journals
eISSN - 1744-8298
pISSN - 1479-6678
DOI - 10.2217/fca-2020-0201
Subject(s) - medicine , sildenafil , tadalafil , vardenafil , covid-19 , hydroxychloroquine , repurposing , erectile dysfunction , severe acute respiratory syndrome , disease , intensive care medicine , infectious disease (medical specialty) , ecology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom